Citeline Podcasts artwork

일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)

Citeline Podcasts

English - August 03, 2023 23:07 - 4 minutes - 9.49 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Medtech Connect Episode 8: Exploring Regulatory Differences In The EU And US
Next Episode: How The Eudamed Medical Device Database Is Progressing Slowly But Surely And the Challenges Ahead

Citeline의 최신 연구보고서에 따르면 미국시장에서 대형 일본제약사들의 항암제, CNS 치료제 허가가능성이 상대적으로 높은 것으로 나타났다. 어떤 요인이 작용했을까? (Scrip 기사를 요약한 내용입니다)

https://scrip.pharmaintelligence.informa.com/SC148677/Whats-Behind-Japan-Firms-Higher-Approval-Rates-In-Challenging-Oncology-CNS-Areas